FDA Patient Safety Strategy Would Shift AE Monitoring To Automated Systems

FDA plans to unveil a broad patient safety strategy over the next few months that will explain how the agency plans to move away from reliance on voluntary reporting to use of automated systems to collect adverse event and medical errors data